The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven effectiveness in extending survival.
2don MSN
Focused ultrasound offers safe and effective prostate cancer treatment, clinical trial finds
A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and treat early prostate cancer while preserving patients' quality of life.
We transformed care for advanced prostate cancer, by validating inhibitors of androgen production as an effective cancer ...
SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.
Focused ultrasound (HIFU) offers safe, effective treatment: Study: Krems, Austria Thursday, November 20, 2025, 11:00 Hrs [IST] A multicenter cl ...
Prostate cancer has become a significant health concern among men, being the second leading cause of death in the United States. While the survival rate in men remains high, those who have advanced, ...
The ARASAFE study showed that a 50 mg/m2 biweekly docetaxel regimen reduced severe side effects compared to the standard 75 mg/m2 triweekly regimen in mHSPC patients. The experimental regimen resulted ...
Risk factors like Gleason score, cancer stage, PSA levels, and genetic markers guide prostate cancer treatment decisions. Treatment options include active surveillance, surgery, radiation, hormone ...
Offers Safe, Effective Treatment A study from Karl Landsteiner University of Health Sciences demonstrates that treatment with focused ultrasound (HIFU) effectively controls prostate cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback